Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
AVNS
BUYAvanos Medical, Inc. · Healthcare · United States · $1.2B · Avg Vol: $21M/d
COMPANY DESCRIPTION
Avanos Medical, Inc. is a medical technology company focused on delivering clinically superior solutions for patient recovery, with products for pain management, respiratory health, and digestive health. The company holds established positions in niche medical device markets through its clinically differentiated products and strong relationships with healthcare providers, providing a competitive edge and resilient demand.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 684.1M | 673.3M | 687.8M | 701.2M | 0.8% | 715.9M | 710.0M | 740.0M | 2.7% |
| EPS | 1.08 | -1.32 | -8.53 | -1.57 | — | -1.60 | — | — | — |
| Shares | 46.5M | 46.2M | 46.0M | 46.5M | -0.2% | 46.8M | — | — | — |
| Debt | 277.0M | 209.1M | 170.2M | 129.1M | -22.5% | 138.4M | — | — | — |
| Equity | 1.3B | 1.2B | 828.5M | 778.2M | -15.5% | — | — | — | — |
| Op CF | 90.9M | 32.4M | 100.7M | 74.7M | -6.3% | 36.7M | — | — | — |
| Inv CF | -135.4M | 21.6M | -27.5M | -60.6M | — | — | — | — | — |
| Fin CF | 56.7M | -94.2M | -49.1M | -37.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AVNS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AVNS | Avanos Medical, Inc.(you) | $1.2B | 72 | BUY |
| IRMD | IRADIMED CORPORATION | $1.2B | 79 | BUY |
| IART | Integra LifeSciences Holdings Corporation | $1.5B | 79 | BUY |
| AHCO | AdaptHealth Corp. | $1.5B | 80 | STRONG BUY |
| ENOV | Enovis Corporation | $1.6B | 82 | STRONG BUY |
| UFPT | UFP Technologies, Inc. | $1.8B | 78 | BUY |
| CNMD | CONMED Corporation | $1.3B | 87 | STRONG BUY |
| INSP | Inspire Medical Systems, Inc. | $1.4B | 56 | HOLD |
| AXGN | Axogen, Inc. | $2.1B | 63 | HOLD |
| ITGR | Integer Holdings Corporation | $3.3B | 73 | BUY |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.6%